{"id":"NCT03743636","sponsor":"Northwestern University","briefTitle":"Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease","officialTitle":"Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease: The NICE Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-10-01","primaryCompletion":"2023-05-23","completion":"2023-05-23","firstPosted":"2018-11-16","resultsPosted":"2025-01-14","lastUpdate":"2025-01-14"},"enrollment":90,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Peripheral Artery Disease"],"interventions":[{"type":"DRUG","name":"Nicotinamide riboside","otherNames":["NR","Niagen"]},{"type":"DRUG","name":"Resveratrol","otherNames":[]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Nicotinamide riboside + resveratrol","type":"ACTIVE_COMPARATOR"},{"label":"Nicotinamide riboside + placebo","type":"ACTIVE_COMPARATOR"},{"label":"Placebo + placebo","type":"PLACEBO_COMPARATOR"}],"summary":"NICE is a randomized clinical trial that will examine the effects of nicotinamide riboside (NR) both with and without resveratrol to test whether, among people with PAD, NR significantly improves walking performance more than placebo and whether NR combined with resveratrol significantly improves walking performance more than placebo. If findings support the hypotheses, results will be used to design a large, definitive randomized clinical.\n\nThe study will randomize 90 participants with PAD to one of the following three groups: NR + resveratrol, NR + placebo, or placebo + placebo.","primaryOutcome":{"measure":"Six-minute Walk Distance (NR Alone vs. Placebo)","timeFrame":"Baseline to 6-month follow-up","effectByArm":[{"arm":"Nicotinamide Riboside + Resveratrol","deltaMin":-6.93,"sd":7.84},{"arm":"Nicotinamide Riboside + Placebo","deltaMin":7,"sd":8.69},{"arm":"Placebo + Placebo","deltaMin":-10.58,"sd":8.45}],"pValues":[{"comp":"OG001 vs OG002","p":"0.0775"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["36588397"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":33},"commonTop":["Diarrhea","Abdominal discomfort","Flushing","Nausea or vomiting"]}}